Old MacDonald's Pharm

First drug from transgenic goats nears approval

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


In the milk of 30 genetically modified goats on GTC Biotherapeutics's farm in Charlton, Mass., is a drug that can literally make your blood flow--the human protein antithrombin, which inhibits clotting. In a dramatic reversal, after European reg-ulators rejected this drug (called ATryn), they now look ready to approve it later this year. The ruling would make ATryn the first human protein made by a transgenic animal for commercial production.

Perhaps more important, the judgment in favor of the goats paves the way for more drug-making transgenic farm animals. Origen Therapeutics in Burlingame, Calif., has developed a versatile, cost-effective method for genetically transforming chickens--one that is on par with creating transgenic mice, now common in the lab. In principle, the birds could produce a variety of different proteins in their eggs, including drugs.

Charles Q. Choi is a frequent contributor to Scientific American. His work has also appeared in The New York Times, Science, Nature, Wired, and LiveScience, among others. In his spare time, he has traveled to all seven continents.

More by Charles Q. Choi
Scientific American Magazine Vol 295 Issue 3This article was published with the title “Old MacDonald's Pharm” in Scientific American Magazine Vol. 295 No. 3 ()
doi:10.1038/scientificamerican092006-4bv0BijOJbgTmUJVrPt5xJ

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe